Daniel Lochner
Chief Financial OfficerMr. Daniel Lochner, MBA, also known as Dan, is Chief Financial Officer at Tectonic Therapeutic, Inc from June 2024. He has with him a wealth of knowledge in corporate finance, business strategy and operations, in addition to of healthcare equity investing experience. Prior to joining Tectonic, he served as Chief Business Officer and Chief Financial Officer of Viatris' Eye Care Division following Viatris acquisition of Oyster Point Pharma, where he had previously served as Chief Financial Officer and Chief Business Officer. At Oyster Point Pharma, he drove business strategy and operational execution while working closely with the executive team and board of directors and played a key role in the companys acquisition. He had been Chief Financial Officer at Oyster Point Pharma, Inc. since July 22, 2019 and was Chief Business Officer from June 28, 2022. Mr. Lochner served as a Managing Director, Vice President and Portfolio Manager at Goldman Sachs Asset Management, L. P. Previously, he was a Managing Director within the Investment Management Division of Goldman Sachs where he served as a lead equity portfolio manager and healthcare investor for various fund strategies. Mr. Lochner joined the Investment Management Division of Goldman Sachs in 2005 as an equity investor, a position he maintained during his tenure at the firm. Mr. Lochner was a part of the US value equity team, where he has broad research responsibilities across the value strategies and oversees the portfolio construction and investment research for the equity portion of the firm’s income builder strategy. Prior to joining the value team, he was an Equity Sales Summer Analyst with Goldman Sachs in 2004. Mr. Lochner received an Executive M.B.A. from Columbia University in 2011 and a B.A. in Economics from the University of Richmond in 2005.
Positions
- Company NameTectonic Therapeutic, Inc.Stock CodeTECXPositionChief Financial OfficerColleagues
- ASAlise S. ReicinPresident, CEO, Secretary & Director
- FNFrancois NaderIndependent Chair of the Board
- MKMarcella Kuhlman RuddyChief Medical Officer
- WAWashington AlvesSenior Vice President of Technical Operations
- PMPeter McNamaraChief Scientific Officer
- TATimothy A. SpringerIndependent Director
- PPPraveen P. TipirneniIndependent Director
- PBPhillip B. DonenbergIndependent Director
